I’m excited to share a comprehensive look at my professional journey across clinical medicine, translational science, biotechnology leadership, and the evolving landscape of precision and AI-enabled drug development. Over the past two decades, I’ve been fortunate to work with extraordinary teams, lead high-impact programs, and contribute to the growth of organizations committed to improving patient lives. Here is my biography.

After decades of leadership in pharmaceutical R&D, I’m excited to share a detailed look at my career journey—from drug discovery to biomarker development, strategic consulting, and beyond. I’ve been fortunate to work alongside exceptional teams and contribute to the development of transformative therapies. Here is my biography.

After more than three decades dedicated to advancing veterinary oncology, translational research, and compassionate clinical care, I’m honored to share this comprehensive view of my professional journey. From pioneering cancer immunotherapies to mentoring the next generation of oncologists, my mission has always centered on improving lives—both animal and human—through innovation and collaboration. Here is my biography.

I'm a biotech executive and scientist with a passion for advancing oncology therapeutics from discovery through clinical development. Over the course of my career, I’ve led R\&D strategy and operations in organizations ranging from early-stage startups to large global pharma, including Takeda, ImmunoGen, Novartis, and Biogen. I’ve had the privilege of building high-performing teams, guiding complex portfolios, and contributing to therapies that make a real difference for patients. Today, I enjoy advising innovative biotech companies and VCs as they shape the next generation of cancer treatments.

After more than 30 years immersed in the world of cell and gene therapy, I've had the privilege to lead, innovate, and mentor across academic, clinical, and industry landscapes. From cleanroom design to regulatory submissions and teaching future leaders, my journey has been defined by purpose and progress. Here is my biography.

Dr. Gilles Besin is a visionary scientific executive whose career spans over 20 years at the forefront of RNA therapeutics and immunology. As Chief Scientific Officer at Orbital Therapeutics, he is redefining the landscape of next-generation RNA medicine through groundbreaking work in mRNA and circular RNA platforms. From leading vaccine development programs to spearheading major biotech acquisitions, Dr. Besin blends deep scientific expertise with strategic insight, positioning him as a driving force in translating cutting-edge research into real-world therapeutic solutions.

Jennifer T. Feldman, MBA, HTL (ASCP), QIHC, is a visionary healthcare business development leader with over 23 years of experience in oncology diagnostics, medical devices, and biotechnology. She has a proven track record of driving strategic partnerships, advancing innovative technologies, and optimizing commercial success in the healthcare industry. Jennifer’s expertise spans clinical pathology, research-use-only applications, and companion diagnostics, making her a key player in transforming patient care. With an MBA in International Business and certifications in histotechnology and immunohistochemistry, she seamlessly blends technical proficiency with business acumen. A sought-after speaker and industry expert, Jennifer is passionate about leveraging her knowledge and leadership to foster innovation, improve healthcare outcomes, and contribute to the future of medical advancements.

Deb Kelly is a pioneering leader in biomedical research, known for her expertise in molecular biophysics, computational modeling, and high-resolution imaging to advance translational medicine. As Executive Director of Structural Oncology LLC and a professor at Penn State University, she has led groundbreaking research in cancer and viral health threats, integrating artificial intelligence and bioinformatics to drive drug discovery and clinical decision-making. With over 15 years of experience managing multidisciplinary teams, securing millions in research funding, and mentoring early-career professionals, Kelly’s work has had a lasting impact on biomedical science. Her strategic leadership, innovative research, and commitment to mentorship continue to shape the future of medical advancements and therapeutic development.

I am excited to share my executive biography, highlighting my journey in oncology, clinical research, and medical affairs over the past 25 years. From my work as a medical science liaison to my leadership in pharmacy education and healthcare consulting, I have been committed to advancing patient care, scientific innovation, and medical education. If you're interested in learning more about my background, expertise, and contributions to pharmaceutical sciences and healthcare strategy.